Prostate-specific antigen (PSA) is a biomarker whose serum levels play a paramount role in every scenario of prostate cancer (PCa): diagnosis, risk-classification, detection of recurrence, therapy monitoring and screening programs [1]. Here, KLK3 is linked to prostate cancer.